Celldex Therapeutics, Inc. - Common Stock (CLDX)
CUSIP: 15117B202
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 67,629,115
- Total 13F shares
- 43,227,306
- Share change
- +7,594,296
- Total reported value
- $2,333,703,184
- Put/Call ratio
- 69%
- Price per share
- $53.99
- Number of holders
- 156
- Value change
- +$430,296,249
- Number of buys
- 92
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 15117B202:
Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
5.8%
|
3,908,947
|
$130,715,000 | — | 30 Jun 2021 | |
| Redmile Group, LLC |
13F
|
Company |
4.5%
|
3,012,081
|
$100,724,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
2,700,650
|
$90,310,000 | — | 30 Jun 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3.1%
|
2,108,908
|
$70,522,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
2,094,218
|
$70,031,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
1,970,406
|
$65,889,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.9%
|
1,962,999
|
$65,642,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
1,818,478
|
$60,810,000 | — | 30 Jun 2021 | |
| VR Adviser, LLC |
13F
|
Company |
1.8%
|
1,240,610
|
$41,486,000 | — | 30 Jun 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
1.5%
|
987,406
|
$33,019,000 | — | 30 Jun 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
1.5%
|
985,000
|
$32,938,000 | — | 30 Jun 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
1.4%
|
968,906
|
$32,400,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
742,699
|
$24,836,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
672,948
|
$22,503,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.87%
|
585,311
|
$19,573,000 | — | 30 Jun 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.83%
|
561,398
|
$18,773,000 | — | 30 Jun 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.74%
|
500,000
|
$16,720,000 | — | 30 Jun 2021 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.68%
|
457,666
|
$15,304,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.64%
|
430,407
|
$14,392,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
412,255
|
$13,786,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.59%
|
399,685
|
$13,365,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.58%
|
389,048
|
$13,010,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.55%
|
371,171
|
$12,412,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
0.54%
|
366,294
|
$12,248,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.54%
|
365,544
|
$12,224,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.54%
|
364,027
|
$12,173,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.53%
|
359,424
|
$12,020,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
338,055
|
$11,305,000 | — | 30 Jun 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.48%
|
323,437
|
$10,816,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.42%
|
285,000
|
$9,530,000 | — | 30 Jun 2021 | |
| AXA S.A. |
13F
|
Company |
0.34%
|
228,951
|
$7,656,000 | — | 30 Jun 2021 | |
| Tri Locum Partners LP |
13F
|
Company |
0.26%
|
175,305
|
$5,862,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
142,031
|
$4,750,000 | — | 30 Jun 2021 | |
| DSAM Partners (London) Ltd |
13F
|
Company |
0.2%
|
135,907
|
$4,545,000 | — | 30 Jun 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.2%
|
134,724
|
$4,505,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
123,155
|
$4,118,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.18%
|
120,254
|
$4,021,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
116,435
|
$3,894,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
106,448
|
$3,560,000 | — | 30 Jun 2021 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.16%
|
105,913
|
$3,542,000 | — | 30 Jun 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.16%
|
105,056
|
$3,513,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
97,625
|
$3,265,000 | — | 30 Jun 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.14%
|
93,116
|
$3,114,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
87,736
|
$2,934,000 | — | 30 Jun 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
9,921
|
$2,926,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
87,200
|
$2,916,000 | — | 30 Jun 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.12%
|
83,865
|
$2,804,000 | — | 30 Jun 2021 | |
| Mirador Capital Partners LP |
13F
|
Company |
0.12%
|
78,679
|
$2,631,000 | — | 30 Jun 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
78,501
|
$2,625,000 | — | 30 Jun 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
76,880
|
$2,571,000 | — | 30 Jun 2021 |
Institutional Holders of Celldex Therapeutics, Inc. - Common Stock (CLDX) as of Q3 2021
As of 30 Sep 2021,
Celldex Therapeutics, Inc. - Common Stock (CLDX) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,227,306 shares.
The largest 10 holders included
FMR LLC, RTW INVESTMENTS, LP, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., EVENTIDE ASSET MANAGEMENT, LLC, and VR Adviser, LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
127
Q3 2021 holders
156
Holder diff
29
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.